EIF2AK3 and Miyoshi myopathy: Based on the hypothesis that targeting various components of the UPR may offer a therapeutic benefit in protein over-secreting tumors such as MM, we sought to investigate the biological effects of a highly selective inhibitor of PERK as a potential anti-MM agent.